Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 30, 2011, Pages 12384-12389

  Watanabe, Akira ^a,b   Ogiwara, Hideki ^a,c   Ehata, Shogo ^c   Mukasa, Akitake ^c   Ishikawa, Shumpei ^a,c   Maeda, Daichi ^c   Ueki, Keisuke ^d   Ino, Yasushi ^c   Todo, Tomoki ^c   Yamada, Yasuhiro ^b   Fukayama, Masashi ^c   Saito, Nobuhito ^c   Miyazono, Kohei ^c   Aburatani, Hiroyuki ^a,e  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Gliomagenesis; Neural differentiation

Indexed keywords

DOXYCYCLINE; FIBROBLAST GROWTH FACTOR 2; NESTIN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CELL GROWTH; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME 13Q; DACH1 GENE; GENE DELETION; GENE DOSAGE; GENE EXPRESSION; GENOTYPE; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPHEROID CELL; TRANSCRIPTION INITIATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

ALLELES; ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 13; DOXYCYCLINE; EYE PROTEINS; FIBROBLAST GROWTH FACTOR 2; GENE DELETION; GENE DOSAGE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; GLIOMA; HOMOZYGOTE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SPHEROIDS, CELLULAR; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 79961092504     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0906930108     Document Type: Article

References (50)

1. Furnari FB, et al. (2007) Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev 21:2683-2710. (Pubitemid 350070717)
2. Holland EC (2001) Gliomagenesis: Genetic alterations and mouse models. Nat Rev Genet 2:120-129.
3. Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170:1445-1453. (Pubitemid 47339290)
4. Ishikawa S, et al. (2005) Allelic dosage analysis with genotyping microarrays. Biochem Biophys Res Commun 333:1309-1314. (Pubitemid 40910145)
5. Zhao X, et al. (2004) An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 64:3060-3071. (Pubitemid 38581405)
6. Nannya Y, et al. (2005) A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 65:6071-6079. (Pubitemid 40994391)
7. Midorikawa Y, et al. (2006) Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene 25:5581-5590. (Pubitemid 44344109)
8. Gaasenbeek M, et al. (2006) Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers. Cancer Res 66:3471-3479.
9. Midorikawa Y, et al. (2009) Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis. Hepatology 49:513-522.
10. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068.
11. Komura D, et al. (2006) Genome-wide detection of human copy number variations using high-density DNA oligonucleotide arrays. Genome Res 16:1575-1584. (Pubitemid 44878496)
12. Ueki K, et al. (1996) CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 56:150-153. (Pubitemid 26010393)
13. Yin Y, ShenWH (2008) PTEN: A new guardian of the genome. Oncogene 27:5443-5453.
14. van Puijenbroek M, et al. (2005) Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: Single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer. J Mol Diagn 7:623-630. (Pubitemid 41601514)
15. Tai AL, et al. (2006) High-throughput loss-of-heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers. Cancer Res 66:4133-4138.
16. Miyazono K, Maeda S, Imamura T (2006) Smad transcriptional co-activators and co-repressors. Smad Signal Transduction, eds Dijke Pt, Heldin C-H (Springer, Dordrechet, The Netherlands), pp 277-293.
17. Wu K, et al. (2007) Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth. Mol Biol Cell 18:755-767. (Pubitemid 46399483)
18. Wu K, et al. (2006) DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. Mol Cell Biol 26:7116-7129. (Pubitemid 44479729)
19. Ikushima H, et al. (2009) Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 5:504-514.
20. Galli R, et al. (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64:7011-7021. (Pubitemid 39331011)
21. Singh SK, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828. (Pubitemid 37187480)
22. Lee J, et al. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9:391-403. (Pubitemid 43668737)
23. Takahashi JA, et al. (1992) Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J Neurosurg 76:792-798.
24. Morrison RS, et al. (1994) Basic fibroblast growth factor and fibroblast growth factor receptor I are implicatedin the growthofhuman astrocytomas. J Neurooncol 18:207-216. (Pubitemid 24209422)
25. Wong KK, et al. (2006) Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array. Cancer Res 66:11172-11178.
26. Fan X, et al. (2002) Genetic profile, PTEN mutation and therapeutic role of PTEN in glioblastomas. Int J Oncol 21:1141-1150.
27. Parsons DW, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812.
28. Yan H, et al. (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765-773.
29. Watanabe T, Nobusawa S, Kleihues P, Ohgaki H (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174:1149-1153.
30. Zhao S, et al. (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324:261-265.
31. Biesiada E, Razandi M, Levin ER (1996) Egr-1 activates basic fibroblast growth factor transcription. Mechanistic implications for astrocyte proliferation. J Biol Chem 271:18576-18581. (Pubitemid 26322719)
32. Xie TX, et al. (2006) Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res 66:3188-3196.
33. Campanelli JT, et al. (2008) Expression profiling of human glial precursors. BMC Dev Biol 8:102.
34. Zhang SC, Wernig M, Duncan ID, Brüstle O, Thomson JA (2001) In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19:1129-1133. (Pubitemid 33115698)
35. Noble M, Mayer-Pröschel M (1997) Growth factors, glia and gliomas. J Neurooncol 35:193-209. (Pubitemid 27511126)
36. Peñuelas S, et al. (2009) TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 15:315-327.
37. Quiñones-Hinojosa A, Chaichana K (2007) The human subventricular zone: A source of new cells and a potential source of brain tumors. Exp Neurol 205:313-324. (Pubitemid 46755774)
38. Sanai N, Alvarez-Buylla A, Berger MS (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353:811-822.
39. Li X, Perissi V, Liu F, Rose DW, Rosenfeld MG (2002) Tissue-specific regulation of retinal and pituitary precursor cell proliferation. Science 297:1180-1183. (Pubitemid 36193352)
40. Li X, et al. (2003) Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature 426:247-254. (Pubitemid 37463137)
41. Mardon G, Solomon NM, Rubin GM (1994) dachshund encodes a nuclear protein required for normal eye and leg development in Drosophila. Development 120:3473-3486. (Pubitemid 24366992)
42. Shen W, Mardon G (1997) Ectopic eye development in Drosophila induced by directed dachshund expression. Development 124:45-52. (Pubitemid 27053005)
43. Lecuit T, Cohen SM (1997) Proximal-distal axis formation in the Drosophila leg. Nature 388:139-145. (Pubitemid 27297443)
44. Machon O, et al. (2002) Forebrain-specific promoter/enhancer D6 derived from the mouse Dach1 gene controls expression in neural stem cells. Neuroscience 112:951-966. (Pubitemid 34667058)
45. Heanue TA, et al. (2002) Dach1, a vertebrate homologue of Drosophila dachshund, is expressed in the developing eye and ear of both chick and mouse and is regulated independently of Pax and Eya genes. Mech Dev 111:75-87. (Pubitemid 34136980)
46. Jing Y, et al. (2011) In vitro differentiation of mouse embryonic stem cells into neurons of the dorsal forebrain. Cell Mol Neurobiol 31:715-721.
47. Wu K, et al. (2011) Cell fate determination factor Dachshund reprograms breast cancer stem cell function. J Biol Chem 286:2132-2142.
48. Louis DN, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109. (Pubitemid 47103521)
49. Watanabe A, et al. (2003) An opposing view on WWOX protein function as a tumor suppressor. Cancer Res 63:8629-8633. (Pubitemid 38064037)
50. Galli R, et al. (2002) Emx2 regulates the proliferation of stem cells of the adult mammalian central nervous system. Development 129:1633-1644. (Pubitemid 34874181)